Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ertapenem vs Comparator in Complicated Intra-abdominal Infections
NCT00157898Phase 4Completed
- Sponsor
- Merck & Co.
- Start
- Jan 2004
- Primary completion
- Aug 2004
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of ertapenem in Intra-abdominal infection (IAI) (2 arms), sponsored by Merck & Co. Primary endpoint: Favorable clinical response. Started Jan 2004; status: completed.
02
Drugs
ertapenem
03
Conditions
Intra-abdominal infection (IAI)
Beyond the preview
Go deeper on NCT00157898.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00157898.